FANJ
TEVA icon

Financial Architects (New Jersey)’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Architects (New Jersey)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-400
Closed -$5K – 717
2020
Q2 		$5K Hold
400
– – ﹤0.01% 732
2020
Q1 		$4K Hold
400
– – ﹤0.01% 737
2019
Q4 		$4K Hold
400
– – ﹤0.01% 792
2019
Q3 		$3K Hold
400
– – ﹤0.01% 893
2019
Q2 		$4K Sell
400
-1,950
-83% -$23.5K ﹤0.01% 1041
2019
Q1 		$36K Buy
2,350
+1,350
+135% +$23.8K 0.01% 708
2018
Q4 		$15K Hold
1,000
– – ﹤0.01% 895
2018
Q3 		$22K Hold
1,000
– – ﹤0.01% 896
2018
Q2 		$24K Sell
1,000
-200
-17% -$4.08K ﹤0.01% 768
2018
Q1 		$21K Sell
1,200
-700
-37% -$13.7K ﹤0.01% 873
2017
Q4 		$36K Sell
1,900
-1,600
-46% -$24.1K 0.01% 777
2017
Q3 		$62K Sell
3,500
-600
-15% -$13.5K 0.01% 619
2017
Q2 		$136K Sell
4,100
-343
-8% -$10.6K 0.02% 408
2017
Q1 		$143K Buy
4,443
+100
+2% +$3.41K 0.03% 368
2016
Q4 		$157K Sell
4,343
-3,748
-46% -$150K 0.04% 296
2016
Q3 		$372K Sell
8,091
-157
-2% -$8.19K 0.1% 165
2016
Q2 		$414K Buy
8,248
+179
+2% +$9.53K 0.12% 149
2016
Q1 		$432K Sell
8,069
-100
-1% -$5.87K 0.15% 115
2015
Q4 		$536K Hold
8,169
– – 0.21% 102
2015
Q3 		$461K Buy
8,169
+467
+6% +$30.3K 0.19% 119
2015
Q2 		$455K Hold
7,702
– – 0.16% 112
2015
Q1 		$480K Sell
7,702
-52
-0.7% -$3.02K 0.19% 104
2014
Q4 		$446K Sell
7,754
-790
-9% -$44K 0.19% 104
2014
Q3 		$459K Buy
8,544
+52
+0.6% +$2.75K 0.22% 99
2014
Q2 		$445K Sell
8,492
-500
-6% -$25.6K 0.21% 100
2014
Q1 		$475K Buy
8,992
+300
+3% +$13.9K 0.28% 88
2013
Q4 		$348K Buy
8,692
+1,279
+17% +$50.4K 0.2% 101
2013
Q3 		$282K Sell
7,413
-30
-0.4% -$1.17K 0.18% 97
2013
Q2 		$292K Buy
+7,443
New +$290K 0.21% 90

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Financial Architects (New Jersey)'s TEVA Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 400 shares — an estimated $5K sold.

Financial Architects (New Jersey) first reported a position in TEVA in Q2 2013 and held it in 29 quarters. The position peaked at $536K in Q4 2015. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Financial Architects (New Jersey) reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 400 Teva Pharmaceuticals shares in Q3 2020, an estimated $5K.
  • Financial Architects (New Jersey) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 29 quarters.
  • Financial Architects (New Jersey)'s Teva Pharmaceuticals position peaked at $536K in Q4 2015.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.